Genotypic and phenotypic heterogeneity of African Americans with primary iron overload

Blood Cells, Molecules, and Diseases

Volumn 31, Issue 3, 2003, Pages 310-319

  Barton, James C ^a,b,e   Acton, Ronald T ^b,c   Rivers, Charles A ^b,c   Bertoli, Luigi F ^a   Gelbart, Terri ^d   West, Carol ^d   Beutler, Ernest ^d  

^a SOUTHERN IRON DISORDERS CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e NONE   (United States)

Author keywords

African American; Ferroportin; Hemochromatosis; Hemoglobinopathy; HFE; HFE C282Y; Iron; Iron overload; Mutation; Thalassemia

Indexed keywords

BETA 2 MICROGLOBULIN; HEPCIDIN; PROTEIN; PROTEIN IRP2; PROTEIN NRAMP2; PROTEIN TFR2; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ANEMIA; ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; GENE FREQUENCY; GENOTYPE; HEPATITIS C; HETEROZYGOSITY; HUMAN; IRON DEFICIENCY; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; NEGRO; PHENOTYPE; PHLEBOTOMY; PRIORITY JOURNAL; UNITED STATES;

HEPATITIS C VIRUS;

EID: 0242636419     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-9796(03)00166-9     Document Type: Article

References (73)

1. Barton J.C., Edwards C.Q., Bertoli L.F., Shroyer T.W., Hudson S.L. Iron overload in African Americans. Am. J. Med. 99:1995;616-623.
2. Wurapa R.K., Gordeuk V.R., Brittenham G.M., Khiyami A., Schecter G.P., Edwards C.Q. Primary iron overload in African Americans. Am. J. Med. 100:1996;9-18.
3. Barton J.C., Alford T.J., Bertoli L.F., Barton N.H., Edwards C.Q. Histochemically demonstrable hepatic iron excess in African Americans. Blood. 86:1995;128a.
4. Gordeuk V., Mukiibi J., Hasstedt S.J., et al. Iron overload in Africa. Interaction between a gene and dietary iron content. N. Engl. J. Med. 326:1992;95-100.
5. Bloom, P.D., Burstein, G.R., Gordeuk, V.R., Iron overload in African Americans, in Barton, J.C., Edwards, C.Q., (Eds.). Hemochromatosis: Genetics, Pathophysiology, Diagnosis, and Treatment, Cambridge Univ. Press, Cambridge, pp. 475-484.
6. Barton J.C., Shih W.W.H., Sawada-Hirai R., Bertoli L.F., Acton R.T., Rothenberg B.E. Caucasian hemochromatosis (H) mutation Cys282Tyr in African American iron overload. J. Invest. Med. 45:1997;62a.
7. Barton J.C., Acton R.T., Edwards C.Q., et al. Iron overload in African Americans phenotypic and genotypic characterization of probands from central Alabama in: A Symposium on Molecular Medicine and Hemochromatosis: At the Crossroads. 2000;43 National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda.
8. Monaghan K.G., Rybicki B.A., Shurafa M., Feldman G.L. Mutation analysis of the HFE gene associated with hereditary hemochromatosis in African Americans. Am. J. Hematol. 58:1998;213-217.
9. Barton J.C., Acton R.T. Inheritance of two HFE mutations in African Americans cases with hemochromatosis phenotypes and estimates of hemochromatosis phenotype frequency. Genet. Med. 3:2001;294-300.
10. Barton J.C., Harman L., Rivers C., Acton R.T. Hemochromatosis association of severity of iron overload with genetic markers. Blood Cells Mol. Dis. 22:1996;195-204.
11. Barton J.C., Rivers C., Harman L., Bertoli L.F., Acton R.T. D6S105 allele 8 (D6S105(8)) frequencies in African American iron overload (AAIO) probands, Caucasian hemochromatosis (H) probands, and normal control subjects from Alabama. Blood. 88:1996;490a.
12. Gordeuk V.R., Caleffi A., Corradini E., et al., Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin) gene, Blood Cells Mol. Dis. 31 (2003) 299-304.
13. Beutler E., Barton J.C., Felitti V.J., et al., Ferroportin (SLC11A3) variant associated with iron overload in African-Americans, Blood Cells Mol. Dis. 31 (2003) 305-309.
14. Barton J.C., Acton R.T. Primary iron overload in African Americans a review of clinical and genetic features. J. Black Nurses Assoc. 12:2001;48-54.
15. McLaren C.E., Barton J.C., Adams P.C., et al. Hemochromatosis and Iron Overload Screening (HEIRS) Study design for an evaluation of 100,000 primary care-based adults. Am. J. Med. Sci. 325:2003;53-62.
16. Bothwell T.H., Charlton R.W., Cook J.D., Finch C.A. Clinical estimation of body iron stores. Bothwell T.H., Charlton R.W., Cook J.D., Finch C.A. Iron Metabolism in Man. 1979;88-104 Blackwell Sci. Oxford.
17. Beutler E., Gelbart T., West C., et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol. Dis. 22:1996;187-194.
18. Lee P.L., Gelbart T., West C., Halloran C., Beutler E. The human Nramp2 gene characterization of the gene structure, alternative splicing, promoter region and polymorphisms. Blood Cells Mol. Dis. 24:1998;199-215.
19. Lee P.L., Gelbart T., West C., Halloran C., Felitti V., Beutler E. A study of genes that may modulate the expression of hereditary hemochromatosis transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin. Blood Cells Mol. Dis. 27:2001;783-802.
20. Acton R.T., Barton J.C., Bell D.S.H., Go R.C.P., Roseman J.M. HFE mutations in African-American women with non-insulin-dependent diabetes mellitus. Ethnic. Dis. 11:2001;578-584.
21. Rivers C.R. Chromosome 6p: Population and family studies of narcolepsy in the southeastern United States, Doctoral Dissertation, University of Alabama at Birmingham, 1999.
22. Acton R.T., Harman L., Go R.C.P., Tseng M.-L., Bias W. Comparison of HLA phenotypes among African Americans from Alabama, Maryland and North Carolina. Transplant. Proc. 25:1993;2404-2407.
23. Edwards C.Q., Griffen L.M., Goldgar D., Drummond C., Skolnick M.H., Kushner J.P. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N. Engl. J. Med. 318:1988;1355-1362.
24. Morrison E.D., Brandhagen D.J., Phatak P., et al. Factors associated with absence of advanced fibrosis among United States patients with phenotypic hereditary hemochromatosis. Ann. Intern. Med. 138:2003;634-638.
25. Barton J.C., McDonnell S.E., Adams P.C., et al. Management of hemochromatosis. Ann. Intern. Med. 129:1990;932-939.
26. Barwick R.C., Jones R.T., Head C.G., et al. Hb Long Island a hemoglobin variant with a methionyl extension at the NHL2L terminus and a prolyl substitution for the normal histidyl residue 2 of the β chain. Proc. Natl. Acad. Sci. USA. 82:1985;4602-4605.
27. Schmidt R.M., Brosius E.M. Basic laboratory methods of hemoglobinopathy detection, Centers for Disease Control Publication 76-8266, U.S. Department of Health, Education, and Welfare, Atlanta, 1974.
28. Betke K., Marti H.R., Schlicht I. Estimation of small percentages of foetal haemoglobin. Nature. 184:1959;1877-1878.
29. Clegg J.B., Naughton M.A., Weatherall D.J. Abnormal hemoglobins separation and characterization of the α and β Chains by chromatography, and the determination of the two new variants, Hb Chesapeake and Hb J (Bangkok). J. Mol. Biol. 19:1966;91-108.
30. Tegos C., Beutler E. A simplified method for studies of haemoglobin biosynthesis. Clin. Lab. Haematol. 2:1980;191-197.
31. Jandl J.H. The hypochromic anemias and other disorders of iron metabolism. Jandl J.H. Blood. Textbook of Hematology. 1987;181-236 Little, Brown, Boston.
32. D.J. Weatherall, D.J., The thalassemias, in: Beutler, E, Lichtman, M.A., Coller, B.S., Kipps, T.J., Seligsohn, U. (Eds.), Williams Hematology, 6th ed., McGraw-Hill, New York, 2001, pp. 547-580.
33. Barton J.C., Shih W.W.H., Sawada-Hirai R., et al. Genetic and clinical description of hemochromatosis probands and heterozygotes evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood Cells Mol. Dis. 23:1997;135-145.
34. Barton J.C., Sawada-Hirai R., Rothenberg B.E., Acton R.T. Two novel missense HFE mutations (I105T and G93R) and confirmation of the S65C mutation in Alabama hemochromatosis probands. Blood Cells Mol. Dis. 25:1999;146-154.
35. Murphy C.C., Acton R.T., Barger B.O., et al. Population genetic analysis of insulin dependent diabetes mellitus using HLA allele frequencies. Clin. Genet. 23:1983;405-414.
36. Albert E.D., Baur M.P., Mayr W.R. Histocompatibility Testing 1984. 1984;Springer-Verlag, Berlin.
37. Merryweather-Clarke A.T., Pointon J.J., Shearman J.D., Robson K.J.H. Global prevalence of putative haemochromatosis mutations. J. Med. Genet. 34:1997;275-278.
38. Jeffery S., Crosby A., Plange-Rhule J., et al. Evidence from a Ghanian population of known African descent to support the proposition that hemochromatosis is a Caucasian disorder. Genet. Test. 3:1999;375-377.
39. Beutler E., Felitti V., Gelbart T., Ho N. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann. Intern. Med. 133:2000;329-337.
40. Jazwinska E.C., Lee S.C., Webb S.I., Halliday J.W., Powell L.W. Localization of the hemochromatosis gene close to D6S105. Am. J. Hum. Genet. 53:1993;347-352.
41. Worwood M., Raha-Chowdhury R., Dorak M.T., Darke C., Bowen D.J., Burnett A.L. Alleles at D6S265 and D6S105 define a haemochromatosis-specific genotype. Br. J. Haematol. 86:1994;863-866.
42. Kuffner T., Whitworth W., Jairam M., McNicholl J. HLA class II and TNF genes in African Americans from the Southeastern United States regional difference in allele frequencies. Hum. Immunol. 64:2003;639-647.
43. Barton J.C., Acton R.T. Transferrin saturation phenotype and HFE genotype screening for hemochromatosis and primary iron overload predictions from a model based on national, racial, and ethnic group composition in central Alabama. Genet. Test. 4:2000;199-206.
44. Njajou O.T., Vaessen N., Joosse M., et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat. Genet. 28:2001;213-214.
45. Montosi G., Donovan A., Totaro A., et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J. Clin. Invest. 108:2001;619-623.
46. Fleming R.E., Sly W.S. Ferroportin mutation in autosomal dominant hemochromatosis loss of function, gain in understanding. J. Clin. Invest. 108:2001;521-522.
47. Njajou O.T., Vaessen N., Oostra B., Heutink P., Van Duijn C.M. The hemochromatosis N144H mutation of SLC11A3 gene in patients with type 2 diabetes. Mol. Genet. Metab. 75:2002;290-291.
48. Devalia V., Carter K., Walker A.P., et al. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Blood. 100:2002;695-697.
49. Roetto A., Merryweather-Clarke A.T., Daraio F., et al. A valine deletion of ferroportin 1 a common mutation in hemochromatosis type 4. Blood. 100:2002;733-734.
50. Wallace D.F., Pedersen P., Dixon J.L., et al. Novel mutation in ferroportin 1 is associated with autosomal dominant hemochromatosis. Blood. 100:2002;692-694.
51. Njajou O.T., de Jong G., Berghuis B., et al. Dominant hemochromatosis due to N144H mutation of SLC11A3 clinical and biological characteristics. Blood Cells Mol. Dis. 29:2002;439-443.
52. Cazzola M., Cremonesi L., Papaioannou M., et al. Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3). Br. J. Haematol. 119:2002;539-546.
53. Bothwell T.H., Abrahams C., Bradlow R.A., Charlton R.W. Idiopathic and Bantu hemochromatosis. Arch. Pathol. 79:1965;63-168.
54. Camaschella C., Roetto A., Cali A., et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat. Genet. 25:2000;14-15.
55. Barton E.H., West P.A., Rivers C.A., Barton J.C., Acton R.T. Transferrin receptor-2 (TFR2) mutation Y250X in Alabama Caucasian and African American subjects with and without primary iron overload. Blood Cells Mol. Dis. 2:2001;279-284.
56. Lee P.L., Halloran C., West C., Beutler E. Mutation analysis of the transferrin receptor-2 gene in patients with iron overload. Blood Cells Mol. Dis. 27:2001;285-289.
57. Conrad M.E. Sickle cell disease and hemochromatosis. Am. J. Hematol. 38:1991;150-152.
58. Castro O., Hasan A., Kaur K., Loyevsky M., Gordeuk V. Hemochromatosis in a non-transfused African-American patient with sickle cell anemia. Blood. 92:1998;13b.
59. Hitender J., Alboronoz M.A., Collazo J., Greenblatt J.M., Draganescu J.M., Matthew M. A rare case report of hemochromatosis in an African-American female. Am. J. Gastroenterol. 95:2000;2580.
60. Beutler E. The sickle cell diseases and related disorders. Beutler E., Lichtman M.A., Coller B.S., Kipps T.J., Seligsohn U. Williams Hematology, 6th ed. 2001;581-605 McGraw-Hill, New York.
61. Nicolas G., Viatte L., Bennoun M., Beaumont C., Kahn A., Vaulont S. Hepcidin, a new iron regulatory peptide. Blood Cells Mol. Dis. 29:2002;327-335.
62. Frazer D.M., Anderson G.J. The orchestration of body iron intake how and where do enterocytes receive their cues. Blood Cells Mol. Dis. 30:2003;288-297.
63. Mendenhall C.L., Moritz T., Rouster S., et al. Epidemiology of hepatitis C among veterans with alcoholic liver disease. The VA Cooperative Study Group 275. Am. J. Gastroenterol. 88:1993;1022-1026.
64. Alter M.J., Kruszon-Moran D., Nainan O.V., et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med. 341:1999;556-562.
65. Howell C., Jeffers L., Hoofnagle J.H. Hepatitis C in African Americans summary of a workshop. Gastroenterology. 119:2000;11385-11396.
66. Batty D.S. Jr., Swanson S.J., Kirk A.D., Ko C.W., Agodoa L.Y., Abbott K.C. Hepatitis C virus seropositivity at the time of renal transplantation in the United States associated factors and patient survival. Am. J. Transplant. 1:2001;179-184.
67. Friedman B.M., Baynes R.D., Bothwell T.H., et al. Dietary iron overload in southern African rural blacks. Afr. Med. J. 78:1990;301-305.
68. Jaskiewicz K., Banach L., Izycka E. Hepatocellular carcinoma in young patients histology, cellular differentiation, HBV infection and oncoprotein p53. Anticancer Res. 15:1995;2723-2725.
69. Ioannou G.N., Dominitz J.A., Weiss N.S., Heagerty P.J., Kowdley K.V. Racial differences in the relationship between hepatitis C infection and iron stores. Hepatology. 37:2003;795-801.
70. Gordeuk V.R., Boyd R.D., Brittenham G.M. Dietary iron overload persists in rural sub-Saharan Africa. Lancet. 1:1986;1310-1313.
71. Bothwell T.H., Charlton R.W., Cook J.D., Finch C.A. Iron loading anemias. Bothwell T.H., Charlton R.W., Cook J.D., Finch C.A. Iron Metabolism in Man. 1979;175-189 Blackwell Sci, Oxford.
72. Barton J.C., Bertoli L.F. Histochemistry of iron and iron-associated proteins in hemochromatosis. Barton J.C., Edwards C.Q. Hemochromatosis Genetics, Pathophysiology, Diagnosis, and Treatment. 2000;200-218 Cambridge Univ. Press, Cambridge.
73. Baynes R.D. Interactions of alcohol, iron and hemochromatosis. Barton J.C., Edwards C.Q. Hemochromatosis Genetics, Pathophysiology, Diagnosis, and Treatment. 2000;468-474 Cambridge Univ. Press, Cambridge.